RxDoctor Payments Data

Steven Paul

Psychiatry · Carmel, INNPI 1124387865

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by Sage Therapeutics, LLC at 50.3% of the total. Reporting peaked in 2021 at $1,004,770 and has fallen 96.2% since, to $38,183 in 2025. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,930,784in general payments, 2019–2025

Across 53 payments — averaging $55,298 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sage Therapeutics, LLC$1.5M
  • Alnylam Pharmaceuticals Inc.$1.4M
  • E.r. Squibb & Sons, L.L.C.$11K

What the payments were for

  • Consulting fees$1,454,30850%
  • Speaking & faculty fees$1,474,15650%
  • Travel & lodging$6540%
  • Food & beverage$1,4130%
  • Gifts$2530%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sage Therapeutics, LLC23$1,475,038
Alnylam Pharmaceuticals Inc.29$1,444,675
E.r. Squibb & Sons, L.L.C.1$11,071

How this compares

$2,930,784 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana →

Other psychiatry in Carmel

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →